Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth R Gore

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Basic & Clinical Pharmacology & Toxicology|April 21, 2006
Immune function tests for hazard identification: a paradigm shift in drug developmentElizabeth R Gore
Toxicology Letters|April 20, 2004
Adequate immunotoxicity testing in drug developmentDanuta J Herzyk, Elizabeth R Gore
Toxicology|March 9, 2004
Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluationElizabeth R Gore, Jill Gower, Edit Kurali, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2018
A hit deconstruction approach for the discovery of fetal hemoglobin inducersAndrew B Benowitz, H Christian Eberl, Connie L Erickson-Miller, et al.
Cytokine|November 21, 2002
Immunopharmacology of recombinant human interleukin-18 in non-human primatesDanuta J Herzyk, Jeanne M Soos, Curtis C Maier, et al.
Journal of Biomolecular Screening|October 29, 2013
Development of phenotypic screening assays for γ-globin induction using primary human bone marrow day 7 erythroid progenitor cellsHu Li, Wensheng Xie, Elizabeth R Gore, et al.
Haematologica|June 27, 2020
<i>In vitro</i> and <i>in vivo</i> induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitorAidan G Gilmartin, Arthur Groy, Elizabeth R Gore, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Basic & Clinical Pharmacology & Toxicology|April 21, 2006
Immune function tests for hazard identification: a paradigm shift in drug developmentElizabeth R Gore
Toxicology Letters|April 20, 2004
Adequate immunotoxicity testing in drug developmentDanuta J Herzyk, Elizabeth R Gore
Toxicology|March 9, 2004
Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluationElizabeth R Gore, Jill Gower, Edit Kurali, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2018
A hit deconstruction approach for the discovery of fetal hemoglobin inducersAndrew B Benowitz, H Christian Eberl, Connie L Erickson-Miller, et al.
Cytokine|November 21, 2002
Immunopharmacology of recombinant human interleukin-18 in non-human primatesDanuta J Herzyk, Jeanne M Soos, Curtis C Maier, et al.
Journal of Biomolecular Screening|October 29, 2013
Development of phenotypic screening assays for γ-globin induction using primary human bone marrow day 7 erythroid progenitor cellsHu Li, Wensheng Xie, Elizabeth R Gore, et al.
Haematologica|June 27, 2020
<i>In vitro</i> and <i>in vivo</i> induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitorAidan G Gilmartin, Arthur Groy, Elizabeth R Gore, et al.
Pageof 1